Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Other Non-Current Liabilities (2016 - 2018)

Armata Pharmaceuticals' Other Non-Current Liabilities history spans 6 years, with the latest figure at $154000.0 for Q3 2018.

  • For Q3 2018, Other Non-Current Liabilities fell 61.5% year-over-year to $154000.0; the TTM value through Sep 2018 reached $154000.0, down 61.5%, while the annual FY2017 figure was $292000.0, 88.05% down from the prior year.
  • Other Non-Current Liabilities for Q3 2018 was $154000.0 at Armata Pharmaceuticals, down from $185000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $20.1 million in Q1 2014 and bottomed at $10000.0 in Q3 2015.
  • The 5-year median for Other Non-Current Liabilities is $1.6 million (2016), against an average of $3.7 million.
  • The largest annual shift saw Other Non-Current Liabilities crashed 99.83% in 2015 before it skyrocketed 16390.0% in 2016.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $5.8 million in 2014, then plummeted by 99.83% to $10000.0 in 2015, then skyrocketed by 24330.0% to $2.4 million in 2016, then crashed by 88.05% to $292000.0 in 2017, then plummeted by 47.26% to $154000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Other Non-Current Liabilities are $154000.0 (Q3 2018), $185000.0 (Q2 2018), and $187000.0 (Q1 2018).